Malcolm Hoenlein
CIK 1294517 · last filed 2026-01-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.18M
Companies
7
Total Filings
37
Lifetime Open-Market Net
$340.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FBIOP | Director | 115,747 | $18.76 | $2.17M | $300.0K | 10 | 2026-01-05 |
| DarioHealth Corp. (DRIOW) Delisted | Director | 78,033 | — | — | $0 | 8 | 2018-06-08 |
| FBIO | Director | 3,667 | $3.39 | $12.4K | $0 | 3 | 2017-07-21 |
| DarioHealth Corp. (DRIO.W) Delisted | Director | 19,168 | — | — | $0 | 1 | 2016-08-17 |
| Fortress Biotech, Inc. (CNDO) Delisted | Director | 55,000 | — | — | $40.2K | 2 | 2014-11-10 |
| KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Director | 110,000 | — | — | $0 | 3 | 2008-11-18 |
| TG THERAPEUTICS, INC. (MHA) Delisted | Director | 4,861 | — | — | $0 | 1 | 2007-04-27 |
Recent Filings · Page 3 of 4
37 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-08-17 | DarioHealth Corp. (DRIO.W) Delisted | Grant (A) | +4,194 | $20.5K | EDGAR |
| 2016-03-28 | FBIO | Grant (A) | — | $0 | EDGAR |
| 2014-11-10 | Fortress Biotech, Inc. (CNDO) Delisted | Buy (P) | +25,000 | $40.2K | EDGAR |
| 2014-02-24 | Fortress Biotech, Inc. (CNDO) Delisted | Grant (A) | +30,000 | $0 | EDGAR |
| 2011-10-12 | — | Grant (A) | +122,549 | $12.5K | |
| 2011-07-08 | — | Grant (A) | +189,394 | $12.5K | |
| 2011-04-22 | — | Grant (A) | +111,607 | $12.5K | |
| 2011-01-04 | — | Grant (A) | +90,580 | $12.5K | |
| 2010-10-12 | — | Grant (A) | +113,636 | $12.5K | |
| 2010-07-14 | — | Grant (A) | +89,268 | $0 |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.